Development of T cell mediated gene therapy for correction of humoral and cytotoxic defects in X-linked lymphoproliferative disease (XLP)

被引：0
|
作者：
Panchal, Neelam [1 ]
Houghton, Benjamin [1 ]
Diez, Begona [1 ]
Thrasher, Adrian [1 ,2 ]
Gaspar, Bobby [1 ,2 ]
Booth, Claire [1 ,2 ]
机构：
[1] UCL GOSH Inst Child Hlth, Mol & Cellular Immunol Sect, London, England
[2] Great Ormond St Hosp Sick Children, Dept Paediat Immunol, London, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
FB02
引用
收藏
页码：A10 / A11
页数：2
相关论文
共 50 条
  • [41] Natural killer cell function in X-linked lymphoproliferative disease
    Benoit, L
    Wang, X
    Aoukaty, A
    Dutz, J
    Tan, R
    FASEB JOURNAL, 2000, 14 (06): : A927 - A927
  • [42] Mutation analysis of the SH2D1A/SAP gene in 4 families affected by X-linked lymphoproliferative disease (XLP).
    Schuster, V
    Hellebrand, H
    Weiss, M
    Steppberger, K
    Sack, U
    Borte, M
    Henze, G
    Strnad, N
    Gierich, J
    Meindl, A
    BLOOD, 2000, 96 (11) : 21A - 21A
  • [43] The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells
    Nagy, N
    Mattsson, K
    Maeda, A
    Liu, AQ
    Székely, L
    Klein, E
    IMMUNOLOGY LETTERS, 2002, 82 (1-2) : 141 - 147
  • [44] Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription
    Ornella Parolini
    Andreas Weinhäusel
    Birgit Kagerbauer
    Joachim Sassmann
    Wolfgang Holter
    Helmut Gadner
    Oskar A. Haas
    Walter Knapp
    Immunogenetics, 2003, 55 : 116 - 121
  • [45] Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription
    Parolini, O
    Weinhäusel, A
    Kagerbauer, B
    Sassmann, J
    Holter, W
    Gadner, H
    Haas, OA
    Knapp, W
    IMMUNOGENETICS, 2003, 55 (02) : 116 - 121
  • [46] A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus
    Lanyi, A
    Li, BF
    Li, SB
    Talmadge, CB
    Brichacek, B
    Davis, JR
    Kozel, BA
    Trask, B
    vandenEngh, G
    Uzvolgyi, E
    Stanbridge, EJ
    Nelson, DL
    Chinault, C
    Heslop, H
    Gross, TG
    Seemayer, TA
    Klein, G
    Purtilo, DT
    Sumegi, J
    GENOMICS, 1997, 39 (01) : 55 - 65
  • [47] Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease
    Houghton, Benjamin C.
    Mussolino, Claudio
    Cathomen, Toni
    Gaspar, H. Bobby
    Booth, Claire
    MOLECULAR THERAPY, 2016, 24 : S130 - S131
  • [48] Targeted gene addition strategies for the treatment of X-linked lymphoproliferative disease
    Houghton, Ben
    Mussolino, Claudio
    Cathomen, Toni
    Gaspar, H. Bobby
    Booth, Claire
    LANCET, 2016, 387 : 21 - 21
  • [49] Targeted gene addition strategies for the treatment of X-linked lymphoproliferative disease
    Houghton, Benjamin
    Mussolino, Claudio
    Cathomen, Toni
    Gaspar, H. Bobby
    Booth, Claire
    HUMAN GENE THERAPY, 2016, 27 (07) : A13 - A13
  • [50] Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP)
    T Hoffmann
    C Heilmann
    HO Madsen
    L Vindeløv
    K Schmiegelow
    Bone Marrow Transplantation, 1998, 22 : 603 - 604
12345